Insider Transactions by Katabi Maha

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VERAVera Therapeutics, Inc.Katabi MahaDirectorMar 21, 2024Sale$44.2081,0093,580,7233,595,690Mar 25, 2024, 09:46 PM
VERAVera Therapeutics, Inc.Katabi MahaDirectorMar 22, 2024Sale$40.51413,45016,748,8593,133,987Mar 25, 2024, 09:46 PM
VERAVera Therapeutics, Inc.Katabi MahaDirectorMar 25, 2024Sale$40.50340,00013,770,0002,793,987Mar 25, 2024, 09:46 PM
RYZBRayzeBio, Inc.Katabi MahaDirectorFeb 26, 2024Option Exercise$62.502,419,528151,220,5000Feb 27, 2024, 04:47 PM
VERAVera Therapeutics, Inc.Katabi MahaDirectorJan 30, 2024Buy$31.00161,2904,999,9903,628,446Feb 01, 2024, 05:58 PM
RYZBRayzeBio, Inc.Katabi MahaDirectorSep 19, 2023Buy$18.00472,2228,499,9961,209,764Sep 21, 2023, 05:10 PM
CINCCinCor Pharma, Inc.Katabi Maha10% OwnerNov 28, 2022Sale$14.326,00085,9200Feb 27, 2023, 09:15 PM
VERAVera Therapeutics, Inc.Katabi MahaDirectorFeb 06, 2023Buy$7.00285,7141,999,9983,467,156Feb 08, 2023, 06:29 PM
CINCCinCor Pharma, Inc.Katabi Maha10% OwnerAug 11, 2022Buy$30.00500,00015,000,0006,073,949Aug 15, 2022, 03:46 PM
VERAVera Therapeutics, Inc.Katabi MahaDirectorFeb 10, 2022Buy$15.00266,6663,999,9903,181,442Feb 14, 2022, 06:17 PM
CINCCinCor Pharma, Inc.Katabi Maha10% OwnerJan 11, 2022Buy$16.00325,0005,200,0005,573,949Jan 13, 2022, 04:38 PM
AVTEAerovate Therapeutics, Inc.Katabi MahaDirectorJul 02, 2021Buy$14.00357,1424,999,9883,758,686Jul 06, 2021, 04:27 PM
BOLTBolt Biotherapeutics, Inc.Katabi Maha10% OwnerFeb 09, 2021Buy$20.00450,0009,000,0002,754,437Feb 09, 2021, 06:04 PM
INZYInozyme Pharma, Inc.Katabi Maha10% OwnerJul 28, 2020Buy$16.00437,5007,000,0002,028,308Jul 28, 2020, 06:08 PM
AKUSAkouos, Inc.Katabi Maha10% OwnerJun 30, 2020Buy$17.0058,823999,9911,515,073Jul 01, 2020, 09:36 PM